80_FR_30574 80 FR 30472 - National Institute on Drug Abuse; Notice of Closed Meetings

80 FR 30472 - National Institute on Drug Abuse; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 102 (May 28, 2015)

Page Range30472-30472
FR Document2015-12899

Federal Register, Volume 80 Issue 102 (Thursday, May 28, 2015) 
[Federal Register Volume 80, Number 102 (Thursday, May 28, 2015)]
[Notices]
[Page 30472]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-12899]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S. C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Multi-site Clinical Trials.
    Date: June 11, 2015.
    Time: 1:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Susan O. McGuire, Ph.D., Scientific Review 
Officer, Office of Extramural Affairs, National Institute on Drug 
Abuse, National Institutes of Health, DHHS, 6001 Executive Blvd., 
Room 4245, Rockville, MD 20852, 301-435-1426, 
[email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)


    Dated: May 22, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-12899 Filed 5-27-15; 8:45 am]
 BILLING CODE 4140-01-P

30472 Federal Register / Vol. 80, No. 102 / Thursday, May 28, 2015 / Notices DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND The meetings will be closed to the HUMAN SERVICES HUMAN SERVICES public in accordance with the provisions set forth in sections National Institutes of Health National Institutes of Health 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and National Eye Institute; Notice of Closed National Institute on Drug Abuse; the discussions could disclose Meetings Notice of Closed Meetings confidential trade secrets or commercial Pursuant to section 10(d) of the property such as patentable material, Pursuant to section 10(d) of the Federal Advisory Committee Act, as and personal information concerning Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is individuals associated with the grant amended (5 U.S.C. App.), notice is hereby given of the following meetings. applications, the disclosure of which hereby given of the following meetings. The meetings will be closed to the would constitute a clearly unwarranted The meetings will be closed to the public in accordance with the invasion of personal privacy. public in accordance with the provisions set forth in sections Name of Committee: National Institute of provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S. Diabetes and Digestive and Kidney Diseases 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., C., as amended. The grant applications Special Emphasis Panel; Time-Sensitive and the discussions could disclose Obesity. as amended. The grant applications and confidential trade secrets or commercial Date: June 24, 2015. the discussions could disclose Time: 1:00 p.m. to 2:00 p.m. property such as patentable material, confidential trade secrets or commercial and personal information concerning Agenda: To review and evaluate grant property such as patentable material, individuals associated with the grant applications. and personal information concerning applications, the disclosure of which Place: National Institutes of Health, Two individuals associated with the grant Democracy Plaza, 6707 Democracy would constitute a clearly unwarranted applications, the disclosure of which Boulevard, Bethesda, MD 20892, (Telephone invasion of personal privacy. Conference Call). would constitute a clearly unwarranted Name of Committee: National Institute on Contact Person: Michele L. Barnard, Ph.D., invasion of personal privacy. Drug Abuse Special Emphasis Panel; Multi- Scientific Review Officer, Review Branch, Name of Committee: National Eye Institute site Clinical Trials. DEA, NIDDK, National Institutes of Health, Special Emphasis Panel; Pathway to Date: June 11, 2015. Room 753, 6707 Democracy Boulevard, Independence (K99) Grant Applications. Time: 1:00 p.m. to 2:00 p.m. Bethesda, MD 20892–2542, (301) 594–8898, Agenda: To review and evaluate grant barnardm@extra.niddk.nih.gov. Date: June 8–10, 2015. applications. Time: 4:00 p.m. to 12:20 p.m. Name of Committee: National Institute of Place: National Institutes of Health, Agenda: To review and evaluate grant Diabetes and Digestive and Kidney Diseases Neuroscience Center, 6001 Executive applications. Special Emphasis Panel; NIDDK Ancillary Boulevard, Rockville, MD 20852, (Telephone Studies on Type 1 Diabetes (PAR–12–265). Place: National Institutes of Health 5635 Conference Call). Contact Person: Susan O. McGuire, Ph.D., Date: June 30, 2015. Fishers Lane, Bethesda, MD 20892 (Virtual Time: 11:00 a.m. to 1:00 p.m. Meeting). Scientific Review Officer, Office of Extramural Affairs, National Institute on Agenda: To review and evaluate grant Contact Person: JEANETTE M HOSSEINI, applications. Drug Abuse, National Institutes of Health, Ph.D., Scientific Review Officer 5635 Fishers Place: National Institutes of Health, Two DHHS, 6001 Executive Blvd., Room 4245, Lane, Suite 1300, Bethesda, MD 20892, 301– Rockville, MD 20852, 301–435–1426, Democracy Plaza, 6707 Democracy 451–2020, jeanetteh@mail.nih.gov. mcguireso@mail.nih.gov. Boulevard, Bethesda, MD 20892, (Telephone Name of Committee: National Eye Institute This notice is being published less than 15 Conference Call). Special Emphasis Panel; NEI Clinical and days prior to the meeting due to the timing Contact Person: Dianne Camp, Ph.D., limitations imposed by the review and Scientific Review Officer, Review Branch, Epidemiology Grant Applications II. funding cycle. DEA, NIDDK, National Institutes of Health, Date: June 18, 2015. Room 756, 6707 Democracy Boulevard, Time: 8:30 a.m. to 11:00 a.m. (Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug Abuse and Bethesda, MD 20892–2542, 301–594–7682, Agenda: To review and evaluate grant campd@extra.niddk.nih.gov. Addiction Research Programs, National applications. Name of Committee: National Institute of Institutes of Health, HHS) Place: National Institutes of Health 5635 Diabetes and Digestive and Kidney Diseases Fishers Lane, Bethesda, MD 20892. Dated: May 22, 2015. Special Emphasis Panel; Innovative Research Contact Person: JEANETTE M HOSSEINI, Michelle Trout, in HIV in KUH (R01). Ph.D., Scientific Review Officer 5635 Fishers Program Analyst, Office of Federal Advisory Date: July 16, 2015. Lane, Suite 1300, Bethesda, MD 20892, 301– Committee Policy. Time: 10:00 a.m. to 2:00 p.m. 451–2020, jeanetteh@mail.nih.gov. Agenda: To review and evaluate grant [FR Doc. 2015–12899 Filed 5–27–15; 8:45 am] applications. (Catalogue of Federal Domestic Assistance BILLING CODE 4140–01–P Place: National Institutes of Health, Two Program Nos. 93.867, Vision Research, Democracy Plaza, 6707 Democracy National Institutes of Health, HHS) Boulevard, Bethesda, MD 20892, (Telephone Dated: May 21, 2015. DEPARTMENT OF HEALTH AND Conference Call). Melanie J. Gray-Pantoja, HUMAN SERVICES Contact Person: Xiaodu Guo, MD, Ph.D., Scientific Review Officer, Review Branch, Program Analyst, Office of Federal Advisory National Institutes of Health DEA, NIDDK, National Institutes of Health, asabaliauskas on DSK5VPTVN1PROD with NOTICES Committee Policy. Room 761, 6707 Democracy Boulevard, [FR Doc. 2015–12799 Filed 5–27–15; 8:45 am] National Institute of Diabetes and Bethesda, MD 20892–5452, (301) 594–4719, BILLING CODE 4140–01–P Digestive and Kidney Diseases; Notice guox@extra.niddk.nih.gov. of Closed Meetings Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Pursuant to section 10(d) of the Special Emphasis Panel; Clinical Sites for Federal Advisory Committee Act, as Studies on Pancreatitis. amended (5 U.S.C. App.), notice is Date: July 28, 2015. hereby given of the following meetings. Time: 8:00 a.m. to 4:30 p.m. VerDate Sep<11>2014 18:18 May 27, 2015 Jkt 235001 PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\28MYN1.SGM 28MYN1


Document Created: 2018-02-21 10:32:51
Document Modified: 2018-02-21 10:32:51
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesJune 11, 2015.
FR Citation80 FR 30472 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR